Skip to main content
hakat - stock.adobe.com

Viral Signaling and Targeting Strategies

Kieser Group

The viral signaling and targeting strategies group investigates the molecular basis of cell transformation by the latent membrane protein 1 (LMP1), the primary oncogene of the human Epstein-Barr tumor virus (EBV). Using state-of-the-art technologies such as proteomics, we focus at elucidating the molecular interactions of LMP1 with the cellular signaling network to define LMP1’s contribution to chronic disease development by EBV infection. The aim is to identify and validate novel targets and to develop targeting strategies such as small molecule inhibitors to interfere with LMP1 signaling and lymphomagenesis by EBV. The relevance of such new targets for other diseases are also investigated.

The viral signaling and targeting strategies group investigates the molecular basis of cell transformation by the latent membrane protein 1 (LMP1), the primary oncogene of the human Epstein-Barr tumor virus (EBV). Using state-of-the-art technologies such as proteomics, we focus at elucidating the molecular interactions of LMP1 with the cellular signaling network to define LMP1’s contribution to chronic disease development by EBV infection. The aim is to identify and validate novel targets and to develop targeting strategies such as small molecule inhibitors to interfere with LMP1 signaling and lymphomagenesis by EBV. The relevance of such new targets for other diseases are also investigated.

Our Scientists

Prof. Dr. Arnd Kieser

Group Leader Viral Signaling and Targeting Strategies

Fabian Giehler

Postdoc Kieser Lab

N. N.

Technical Assistant Kieser Lab

Open Positions

Now Hiring: Technical Assistent

Our Publications

Read more

Contact

Prof. Dr. Arnd Kieser

Group Leader Viral Signal Transduction and Therapeutic Intervention Strategies